| Title |
Published |
Price |
|
CTI BioPharma Corp (CTIC) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 51
|
05 April, 2017 |
$
125 |
|
Chugai Pharmaceutical Co Ltd (4519) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 54
|
05 April, 2017 |
$
125 |
|
Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 55
|
05 April, 2017 |
$
125 |
|
Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 60
|
05 April, 2017 |
$
125 |
|
Mymetics Corp (MYMX) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 35
|
05 April, 2017 |
$
125 |
|
Acadia Pharmaceuticals Inc (ACAD) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 50
|
05 April, 2017 |
$
125 |
|
Keryx Biopharmaceuticals Inc (KERX) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 46
|
05 April, 2017 |
$
125 |
|
Sangamo Therapeutics Inc (SGMO) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 53
|
05 April, 2017 |
$
125 |
|
F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 84
|
05 April, 2017 |
$
125 |
|
AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review
By: GlobalData | Published Date : 05 April, 2017 | No of Pages : 87
|
05 April, 2017 |
$
125 |
|
